Nascent Biotech, Inc. (NBIO)
NBIO Stock Price Chart
Explore Nascent Biotech, Inc. interactive price chart. Choose custom timeframes to analyze NBIO price movements and trends.
NBIO Company Profile
Discover essential business fundamentals and corporate details for Nascent Biotech, Inc. (NBIO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
3 Dec 2009
Employees
—
Website
https://www.nascentbiotech.comCEO
Sean Carrick
Description
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.
NBIO Financial Timeline
Browse a chronological timeline of Nascent Biotech, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Jun 2025
Earnings released on 29 May 2025
Earnings released on 28 Feb 2025
Earnings released on 18 Nov 2024
EPS came in at -$0.00 .
Earnings released on 14 Aug 2024
EPS came in at -$0.00 .
Earnings released on 1 Jul 2024
EPS came in at -$0.00 , while revenue for the quarter reached $3.38 .
Earnings released on 14 Feb 2024
EPS came in at -$0.00 .
Earnings released on 9 Nov 2023
EPS came in at -$0.01 .
Earnings released on 18 Aug 2023
EPS came in at -$0.00 .
Earnings released on 29 Jun 2023
EPS came in at -$0.00 .
Earnings released on 14 Feb 2023
EPS came in at -$0.01 .
Earnings released on 10 Nov 2022
EPS came in at -$0.00 .
Earnings released on 9 Aug 2022
EPS came in at -$0.01 .
Earnings released on 15 Jun 2022
EPS came in at -$0.00 .
Earnings released on 14 Feb 2022
EPS came in at $0.01 , while revenue for the quarter reached $1.00M .
Earnings released on 4 Nov 2021
EPS came in at -$0.00 .
Earnings released on 12 Aug 2021
EPS came in at -$0.00 .
Earnings released on 8 Jul 2021
EPS came in at $0.01 , while revenue for the quarter reached $750.00K .
Earnings released on 9 Feb 2021
EPS came in at -$0.01 .
Earnings released on 16 Nov 2020
EPS came in at -$0.01 .
NBIO Stock Performance
Access detailed NBIO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.